Antistreptococcal activity of gatifloxacin

Drugs

Volumn 58, Issue SUPPL. 2, 1999, Pages 164-166

  Jones, Ronald N ^a   Johnson, David M ^a   Erwin, Meridith E ^a   Beach, Mondell L ^a   Biedenbach, Douglas J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GATIFLOXACIN; OFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TROVAFLOXACIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBACTERIAL ACTIVITY; BETA HEMOLYTIC STREPTOCOCCUS; CONFERENCE PAPER; NONHUMAN; STREPTOCOCCUS PNEUMONIAE;

STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0032733725     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199958002-00045     Document Type: Conference Paper

References (6)

1. Bauernfeind A. Comparison of the antibacterial activities of the quinolones BAY 12-8039, gatifloxacin (AM-1155), trovafloxacin, clinafloxacin, levofloxacin, and ciprofloxacin. J Antimicrob Chemother 1997; 40: 639-51
2. Hosaka M, Yasue T, Fukuda H, et al. In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone. Antimicrob Agents Chemother 1992; 36: 2108-17
3. Wakahayashi E, Mitsuhashi S. In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone. Antimicrob Agents Chemother 1994; 38: 594-601
4. Wise R, Brenwald NP, Andres JM. The activity of the methylpiperazinyl fluoroquinolone CG 5501 : a comparison with other fluoroquinolones. J Antimicrob Chemother 1997; 39: 447-52
5. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests, 6th ed. Approved standard. Wayne, PA, NCCLS: 1997
6. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard M7-A4. Wayne, PA, NCCLS: 1997